Molecular markers

a technology of molecular markers and markers, applied in the field of gene sequences, can solve the problems of false sense of security, unwarranted and ineffective treatment and/or unnecessary patient anxiety, and process can be quite slow

Inactive Publication Date: 2009-04-02
HUI KAM MAN +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

Provides sensitive and objective diagnostic aids for early detection and prognosis of cervical cancer, reducing unnecessary treatments and improving the identification of progressive lesions.

Problems solved by technology

This process can be quite slow.
However, use of a positive HPV DNA test as the only parameter to dictate more in-depth evaluation of the patient may lead to unwarranted and ineffective treatment and / or unnecessary patient anxiety.
Conversely, current technology may be too insensitive to detect small amounts of potentially tumorigenic HPV types leading to a false sense of security.
However, these tests are expensive and can be invasive.
However, the molecular pathways leading to cervical dysplasia remain poorly understood.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Molecular markers
  • Molecular markers
  • Molecular markers

Examples

Experimental program
Comparison scheme
Effect test

example 1

Tissue Collection and RNA Isolation

[0064]Biopsies were collected from patients with squamous carcinoma of the cervix. Punch biopsies with tischler forceps were taken from the tumor lesion for histo-pathological assessment as well as for RNA analysis. For histo-pathological analysis, the tissues were fixed in 10% buffered formalin and processed into paraffin blocks. Multiple step sections were made and stained with hematoxylin and eosin. Where indicated, PAS with and without diastase digestion and mucicarmine stains were performed. Tissues collected for RNA analysis were snapped frozen in liquid nitrogen. Wherever possible, normal cervical tissues far away from the tumor areas were taken for controls. The staging of cancer was done according to recommendations by the International Federation of Obstetrics and Gynacology (FIGO) [FIGO News, 1987). To avoid repetition in evaluating gene expression in the same patient, different patients were included in different studies. In total, 38 c...

example 2

cDNA Cloning and Sequencing

[0067]Re-amplified cDNA fragments were cloned into either the pCR2.1 vector using the TA cloning system from Invitrogen (San Diego, Calif.) or the pCR-TRAP Vector from GenHunter (GenHunter Corp. Nashville, Tenn.). DNA sequencing was performed either using Sequenase Kit Version 2.0 (United States Biochemical, Cleveland, Ohio), or by automated sequencing using ABI Prism 377 DNA Sequencer (Perkin-Elmer Corp., Norwalk, Conn.). The nucleotide sequences obtained were analyzed by BLAST search (National Centre for Biotechnology Information).

example 3

cDNA Microarray Fabrication and Hybridization

[0068]cDNA clones were amplified in 100 μl PCR reactions, 5 μl PCR product was analyzed on a 2% w / v agarose gel after which the remaining PCR products were purified by isopropanol precipitation, resuspended in 15 μl 3×SSC and printed onto poly-L-lysine (Sigma Microsystems Inc., Woburn, Mass.). Housekeeping genes including G3PDH, β-actin, β-2-microglobulin, α-tubulin, cyclophilin and ubiquitin were also spotted as internal controls for normalization. Each slide was hydrated for 2-3 sec over a steaming 100° C. water-bath, snap-dried for 5 see on a 100° C. heating block and crosslinked with 550 mJ ultraviolet irradiation using a Stratalinker (Stratagene, LaJolla, Calif.). The slide was then washed for 10 min in 0.2% w / v SDS and rinsed 5× in distilled water before being denatured for 5 min in 100° C. distilled water, desiccated for 5 min in 95% v / v ethanol and air-dried for 5 min in an 80° C. oven.

[0069]Comparative hybridizations were carried...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

The present invention relates to genetic sequences exhibiting differential expression patterns in cancer tissue relative to normal tissue. The identification of such sequences permits their use as molecular markers for cancer, as early indicators of cancer progression and / or as predictive markers for a propensity or likelihood of a cancer to develop. The present invention relates particularly to genetic sequences exhibiting expression patterns up-regulated in cervical cells or associated with pre-, early- or late-onset cervical cancer relative to normal cervical cells, such sequences serving as biomarkers. The biomarkers of the present invention provide targets for the development of therapeutic protocols for the treatment or prophylaxis of cervical or related cancer. Such therapeutic protocols are directed to inhibiting expression of the marker or inhibiting the expression product of the marker. The invention is further directed to a method for identifying molecular markers which are useful indicators of cervical cancer and / or its progression.

Description

FIELD OF THE INVENTION[0001]The present invention relates generally to genetic sequences exhibiting differential expression patterns in cancer tissue relative to normal tissue. The identification of differentially expressed genetic sequences permits their use as molecular markers for cancer, as early indicators of cancer progression and / or as predictive markers for a propensity or likelihood of a cancer to develop. The present invention relates particularly to genetic sequences exhibiting expression patterns up-regulated in cervical cells or associated with pre-, early- and / or late-onset cervical cancer relative to normal cervical cells. The genetic sequences of the present invention provide markers for pre-, early- or late-onset cervical cancer and / or a cancer related to cervical cancer. The markers of the present invention further provide potential targets for the development of therapeutic protocols for the treatment or prophylaxis of cervical or related cancer. Such therapeutic ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C07H21/04C12Q1/68C07K14/47C12N15/09G01N33/566C12Q1/6886G01N33/574
CPCC12Q1/6886C12Q2600/112C12Q2600/158
InventorHUI, KAM MANCHENG, QING
OwnerHUI KAM MAN